A hypomorphic model of CPS1 deficiency for investigating the effects of hyperammonemia on the developing nervous system

A hypomorphic model of CPS1 deficiency for investigating the effects of hyperammonemia on the developing nervous system

Saved in:

Bibliographic Details
Main Authors:	Stuti Bakshi, Taryn Diep, Brandon J. Willis, Rachel Reyes, Grace F. Wu, Georgios Makris, Martin Poms, Isabel Day, Qin Sun, Irina Zhuravka, Lindsay Lueptow, Michelle Tang, Gareth A. Cromie, Aimée M. Dudley, Johannes Häberle, Gerald S. Lipshutz
Format:	Article
Language:	English
Published:	The Company of Biologists 2025-07-01
Series:	Disease Models & Mechanisms
Subjects:	carbamoyl phosphate synthetase 1 deficiency human mutation enzyme activity hyperammonemia glutamine
Online Access:	http://dmm.biologists.org/content/18/7/dmm052303
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of an oversized AAV8 vector for CPS1 deficiency results in long-term survival and ammonia control
by: Taryn Diep, et al.
Published: (2025-03-01)

Carbamoyl phosphate synthetase 1 deficiency manifested in an adult treated with prednisone for polymyositis, and cured by live-donor liver transplantation
by: Kazuhiro Yokota, et al.
Published: (2025-06-01)

Identification of novel variants in carbamoyl phosphate synthetase 1 gene and comparative pathogenicity assessments of CPS1 missense variants following ACMG/AMP-ClinGen recommendation for computational tools
by: Fei Li, et al.
Published: (2025-06-01)

Valproate Metabolites and Hyperammonemia
by: J Gordon Millichap
Published: (1992-07-01)

Possibility of medicinal correction of disorders in metabolic cycle of neurotoxic transmitter glutamate in retina with neurotropic drugs during experimental glaucoma
by: V. M. Serdyuk
Published: (2012-08-01)

Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker
by: Khaa Hoo Ong, et al.
Published: (2023-07-01)

Glufosinate constrains synchronous and metachronous metastasis by promoting anti‐tumor macrophages
by: Alessio Menga, et al.
Published: (2020-09-01)

Carbamoly-phosphate synthetase 1 (CPS1) deficiency: A tertiary center retrospective cohort study and literature review
by: Mahmood Noori, et al.
Published: (2024-12-01)

Characterization of glutamine synthetase involved in the fecundity of Rhopalosiphum padi
by: Xing-Ye Li, et al.
Published: (2025-07-01)

An acute life-threatening episode of rhabdomyolysis, renal failure, altered mental status and hyperammonemia in an adult with 3-methylcrotonyl-CoA carboxylase deficiency
by: Rachel McGowan, et al.
Published: (2024-12-01)

Glutamate Metabolism in Brain Structures in Experimental Hemorrhagic Shock
by: V. N. Jakovlev, et al.
Published: (2017-03-01)

Diagnostic and Prognostic Value of Hyperammonemia in Patients with Liver Cirrhosis, Hepatic Encephalopathy, and Sarcopenia (Experts’ Agreement)
by: M. Yu. Nadinskaia, et al.
Published: (2024-03-01)

Hyperinsulinism–hyperammonemia syndrome associated with GLUD1 gene mutation: a case series
by: Miral M. Abdulghfar, et al.
Published: (2025-07-01)

Asparagine synthetase modulates glutaminase inhibitor sensitivity through metabolic reprogramming and serves as a prognostic biomarker in hepatocellular carcinoma
by: Benjian Gao, et al.
Published: (2025-10-01)

Enzymatic Activity Responses to Transport and Low-Temperature Storage: Implications for Plant Nitrogen Metabolism Studies
by: D. Nayeli Martínez, et al.
Published: (2025-01-01)

2-oxoglutarate triggers assembly of active dodecameric Methanosarcina mazei glutamine synthetase
by: Eva Herdering, et al.
Published: (2025-03-01)

Hyperammonemia heightens anesthetic sensitivity in male rats with acute hepatic encephalopathy via affecting brain areas represented by the cerebellum
by: Sa Wang, et al.
Published: (2025-07-01)

FBXL4-related encephalomyopathic mitochondrial DNA depletion syndrome: A rare cause of hyperammonemia
by: Ayça Burcu Kahraman, et al.
Published: (2025-06-01)

Liver resection for a congenital intrahepatic portosystemic shunt in a child with hyperammonemia and hypermanganesemia: a case report
by: Yuichi Takama, et al.
Published: (2020-04-01)

Hiperamonemia secundária ao uso terapêutico de ácido valpróico: relato de caso Hyperammonemia secondary to the use of valproic acid: case report
by: Marlene de Fátima Turcato, et al.
Published: (2005-06-01)

Drought is a lesser evil than cold for photosynthesis and assimilation metabolism of maize
by: Kamirán Á. Hamow, et al.
Published: (2024-12-01)

Structural Analysis and Substrate Specificity of D-Carbamoylase from <i>Pseudomonas</i>
by: Marina Paronyan, et al.
Published: (2024-10-01)

Valproate-induced Hyperammonemic Encephalopathy
by: Hsiao-Feng Chou, et al.
Published: (2008-10-01)

The role of glutamine synthetase expression and cystine/glutamate transporter (SLC7A11, xCT) in epilepsy pathogenesis of patients with supratentorial brain gliomas
by: M. Yu. Prokudin, et al.
Published: (2022-07-01)

Hepatogenic weakness as a clinical marker of hyperammonemia and of the effectiveness of its correction in patients with pre-cirrhotic stages of non-alcoholic fatty liver disease
by: E. M. Petrova, et al.
Published: (2021-06-01)

Case Report: Management of intracranial hypertension in acute-on-chronic liver failure: a case of fulminant cerebral edema and acute-onset severe hyperammonemia in a patient with cirrhosis
by: Wei Tang, et al.
Published: (2025-03-01)

A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab
by: Mauro Passucci, et al.
Published: (2023-01-01)

HMG‐CoA Synthase‐2 Deficiency: Neonatal Hyperammonemic Coma and Abnormal Metabolic Screening Resembling Maple Syrup Urine Disease
by: Hathaipat Vaseenon, et al.
Published: (2025-07-01)

On the use of glutamine-containing specialty foods in sports
by: A. V. Slivin, et al.
Published: (2022-05-01)

P007: A case series and functional study of two commonly reported pathogenic variants in OTC supports a hypomorphic classification
by: Steven Lang, et al.
Published: (2025-01-01)

The small and large subunits of carbamoyl-phosphate synthase exhibit diverse contributions to pathogenicity in Xanthomonas citri subsp. citri
by: Jing GUO, et al.
Published: (2015-07-01)

The problem of hyperammoniemia after orthotopic liver transplantation
by: S. V. Zhuravel, et al.
Published: (2025-06-01)

First manifestation of citrullinemia type I as Sandifer syndrome
by: Mustafa Kılıç, et al.
Published: (2017-12-01)

Prior immunity to Ureaplasma urealyticum protects against respiratory infection in immunosuppressed mice
by: Maha Y. Al-Jabri, et al.
Published: (2025-01-01)

Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
by: Ding Nan, et al.
Published: (2025-01-01)

[18F]FDG-PET and [18F]MPPF-PET are brain biomarkers for the creatine transporter Slc6a8 loss of function mutation
by: Isabel Day, et al.
Published: (2025-03-01)

Valproate-induced hyperammonemic encephalopathy: the role of clinical pharmacists in medication safety—a case report
by: Wei Chen, et al.
Published: (2025-07-01)

Acute hyperammonemic encephalopathy masquerading as postoperative delirium in a patient who underwent lung surgery: a case report
by: Chao-Qin Chen, et al.
Published: (2025-07-01)

The impact of continuous renal replacement therapy for metabolic disorders in infants
by: Fatih Aygun, et al.
Published: (2018-02-01)

Protective effects of L-glutamine against toxicity of&nbsp;deltamethrin in the cerebral tissue
by: Varol S, et al.
Published: (2016-04-01)